Shao Jian Lin

581 total citations
14 papers, 447 citations indexed

About

Shao Jian Lin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Shao Jian Lin has authored 14 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Shao Jian Lin's work include Pituitary Gland Disorders and Treatments (5 papers), Glioma Diagnosis and Treatment (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Shao Jian Lin is often cited by papers focused on Pituitary Gland Disorders and Treatments (5 papers), Glioma Diagnosis and Treatment (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Shao Jian Lin collaborates with scholars based in China, United States and India. Shao Jian Lin's co-authors include Zhe Wu, Lin Cai, Wei Zhao, Yu Yao, Yu Guo, Han Bing Shang, Liang Zhou, Ze Wu, Wei-Dong Le and Ying Mao and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Brain Research.

In The Last Decade

Shao Jian Lin

14 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shao Jian Lin China	12	214	151	151	91	71	14	447
Han Bing Shang China	8	225 1.1×	120 0.8×	187 1.2×	46 0.5×	53 0.7×	9	381
Sandy Hsu United States	9	248 1.2×	85 0.6×	131 0.9×	36 0.4×	73 1.0×	9	404
Guanglong Huang China	12	100 0.5×	95 0.6×	67 0.4×	40 0.4×	76 1.1×	29	327
Fangfang Jian China	12	180 0.8×	113 0.7×	91 0.6×	62 0.7×	29 0.4×	18	356
Silvina Gutiérrez Argentina	14	202 0.9×	238 1.6×	64 0.4×	36 0.4×	41 0.6×	44	471
Catarina Darnfors Sweden	15	213 1.0×	169 1.1×	71 0.5×	162 1.8×	30 0.4×	18	503
Jacek Kunicki Poland	11	120 0.6×	173 1.1×	49 0.3×	105 1.2×	76 1.1×	36	353
Zsófia Tömböl Hungary	11	188 0.9×	115 0.8×	285 1.9×	203 2.2×	43 0.6×	14	419
Nicoletta Charolidi United Kingdom	8	190 0.9×	143 0.9×	33 0.2×	52 0.6×	77 1.1×	11	370
P Mora Germany	12	147 0.7×	307 2.0×	246 1.6×	330 3.6×	46 0.6×	12	604

Countries citing papers authored by Shao Jian Lin

Since Specialization

Citations

This map shows the geographic impact of Shao Jian Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao Jian Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao Jian Lin more than expected).

Fields of papers citing papers by Shao Jian Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shao Jian Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao Jian Lin. The network helps show where Shao Jian Lin may publish in the future.

Co-authorship network of co-authors of Shao Jian Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shao Jian Lin. A scholar is included among the top collaborators of Shao Jian Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shao Jian Lin. Shao Jian Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Huang, Hai, Shao Jian Lin, Wei Zhao, & Zhe Wu. (2018). Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review. Metabolic Brain Disease. 33(3). 969–976. 16 indexed citations

Lin, Shao Jian, et al.. (2017). Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis. Endocrine. 59(1). 50–61. 36 indexed citations

Lin, Shao Jian, Ze Wu, Yu Guo, et al.. (2017). Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death. Autophagy. 13(8). 1404–1419. 81 indexed citations

Lin, Shao Jian, Ze Wu, Lei Cao, et al.. (2017). Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine. The Journal of Clinical Endocrinology & Metabolism. 102(10). 3692–3703. 30 indexed citations

Wu, Ze, Ze Wu, Yong Zhang, et al.. (2016). Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup. International Journal of Endocrinology. 2016. 1–7. 10 indexed citations

Wu, Zhe, Lin Cai, Shao Jian Lin, et al.. (2015). Heat Shock Protein 47 Promotes Glioma Angiogenesis. Brain Pathology. 26(1). 31–42. 38 indexed citations

Cai, Lin, Yu Guo, Shao Jian Lin, et al.. (2015). Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas. Endocrine. 52(3). 641–651. 17 indexed citations

Lin, Shao Jian, Yu Guo, Lin Cai, et al.. (2015). Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline. Oncotarget. 6(36). 39329–39341. 37 indexed citations

Wu, Zhe, Chao Qiu, Anli Zhang, et al.. (2014). Glioma-Associated Antigen HEATR1 Induces Functional Cytotoxic T Lymphocytes in Patients with Glioma. Journal of Immunology Research. 2014. 1–12. 24 indexed citations

10.

Wu, Zhe, Shao Jian Lin, Lin Cai, et al.. (2014). MicroRNA expression profile of bromocriptine-resistant prolactinomas. Molecular and Cellular Endocrinology. 395(1-2). 10–18. 40 indexed citations

11.

Wu, Zhe, Lin Cai, Chao Qiu, et al.. (2014). CTL responses to HSP47 associated with the prolonged survival of patients with glioblastomas. Neurology. 82(14). 1261–1265. 14 indexed citations

12.

Li, Hao, et al.. (2013). [Fine-needle aspiration with measurement of parathyroid hormone levels in thyroidectomy].. PubMed. 48(11). 934–8. 5 indexed citations

13.

Wu, Zhe, Lin Cai, Shao Jian Lin, et al.. (2013). High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance. Neuro-Oncology. 15(9). 1264–1275. 41 indexed citations

14.

Wu, Zhe, et al.. (2013). The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas. Brain Research. 1529. 16–25. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact